Scandinavian ChemoTech AB (OSTO:CMOTEC B) ROCE % : -212.21% (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Scandinavian ChemoTech AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Scandinavian ChemoTech AB's annualized ROCE % for the quarter that ended in Mar. 2025 was -212.21%.

Scandinavian ChemoTech AB ROCE % Historical Data

The historical data trend for Scandinavian ChemoTech AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scandinavian ChemoTech AB ROCE % Chart

Scandinavian ChemoTech AB Annual Data

Trend

Jun15

Jun16

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-113.10

-102.80

-109.99

-157.36

-147.42

Scandinavian ChemoTech AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
ROCE %	Get a 7-Day Free Trial															-118.32	-266.74	-205.83	-163.85	-212.21

Scandinavian ChemoTech AB ROCE % Calculation

Scandinavian ChemoTech AB's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-12.539	/	( ( (14.869 - 3.838)	+	(13.38 - 7.4) )	/ 2 )
	=	-12.539	/	( (11.031	+	5.98)	/ 2 )
	=	-12.539	/	8.5055
	=	-147.42 %

Scandinavian ChemoTech AB's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2025 )		(Q: Dec. 2024 )		(Q: Mar. 2025 )
	=	-10.268	/	( ( (13.38 - 7.4)	+	(13.069 - 9.372) )	/ 2 )
	=	-10.268	/	( ( 5.98	+	3.697 )	/ 2 )
	=	-10.268	/	4.8385
	=	-212.21 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2025) EBIT data.

Scandinavian ChemoTech AB (OSTO:CMOTEC B) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Scandinavian ChemoTech AB ROCE % Related Terms

Thank you for viewing the detailed overview of Scandinavian ChemoTech AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Scandinavian ChemoTech AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandinavian ChemoTech AB (OSTO:CMOTEC B) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheelevagen 1, Medicon Village, Lund, SWE, 223 63

Website

https://www.chemotech.se

Scandinavian ChemoTech AB is a Sweden based clinical development company. It is engaged in research on pain management and therapy for prostate cancer.

Scandinavian ChemoTech AB Headlines

No Headlines